Monoclonal-antibody therapy in systemic vasculitis.
Mathieson
P W
PW
Department of Medicine, University of Cambridge, Addenbrooke's Hospital, United Kingdom.
Cobbold
S P
SP
Hale
G
G
Clark
M R
MR
Oliveira
D B
DB
Lockwood
C M
CM
Waldmann
H
H
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000032:analysis; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D000917:Antibody Formation; D001327:Autoimmune Diseases / Q000628:therapy*; D001402:B-Lymphocytes / Q000276:immunology; D015704:CD4 Antigens / Q000276:immunology*; D003208:Concanavalin A / Q000494:pharmacology; D006801:Humans; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D051381:Rats; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D013745:Tetanus Toxoid / Q000276:immunology; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000628:therapy*
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D015704:CD4 Antigens; D011994:Recombinant Proteins; D013745:Tetanus Toxoid; D003208:Concanavalin A